Drug to Treat Parkinsonís Disease Launched in the US Market by Dr Reddy's Laboratories

by Lakshmi Darshini on  August 13, 2015 at 6:07 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson's disease has been launched by Dr Reddy's Laboratories in the US market.
Drug to Treat Parkinsonís Disease Launched in the US Market by Dr Reddy's Laboratories
Drug to Treat Parkinsonís Disease Launched in the US Market by Dr Reddy's Laboratories

It has launched the tablets in the strengths of 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in the US market following approval from the US Food & Drug Administration (USFDA), said Dr Reddy's Laboratories.

The company's product is generic version of Mirapex ER tablets. "The Mirapex ER brand and generic had US sales of approximately USD 48.3 million MAT for the most recent twelve months ending in June 2015 according to IMS Health," it said.

The DRL product is available in bottle count sizes of 30, it added.

Source: PTI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Nutritional Management of Parkinsons disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive